Instrucciones de búsqueda:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Navegar por los elementos (107 total)
-
Autor: NETEC
Tema: Treatment & Care
Tipo de elemento: Webinar
Fecha de actualización: 2020-11-25
Descripción: In this webinar, we will identify important considerations involving Monoclonal Antibody Therapeutics available for emergency use authorization (EUAs) for mild-to-moderate COVID-19 cases, discuss recent criteria for the FDA approved investigational… -
Autor: NETEC
Tema: Treatment & Care
Tipo de elemento: Webinar
Fecha de actualización: 2020-11-18
Descripción: In this webinar, we will discuss current evidence surrounding clinical trials for COVID-19 therapeutics including ACTT1, ACTT2, and ACTT3, and describe the FDA's Coronavirus Treatment Acceleration Program (CTAP) when determining new treatments for… -
Autor: Normand, Sharon-Lise T.
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2020-07-21
Descripción: In a platform trial, patients with a single disease are randomly assigned to a group of different therapies on the basis of a decision algorithm to determine whether any therapy has benefit. -
Autor: Meng, Xianmin, Yun Ling, Li Zhang, Qian Zhang, Ping Dong, Tongyu Zhu, and Hongzhou Lu.
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2020-06-11
Descripción: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has become a serious public health threat to the whole world, and the number of infected is still rising dramatically at this moment. Several studies have confirmed that cytokine…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Autor: the ACTT-1 Study Group Members
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2020-05-22
Descripción: Discussing "a double-blind, randomized, placebo-controlled trial of intravenous remdesivir in adults hospitalized with Covid-19 with evidence of lower respiratory tract involvement." -
Autor: Grein, Jonathan, Norio Ohmagari, Daniel Shin, George Diaz, Erika Asperges, Antonella Castagna, Torsten Feldt, Gary Green, Margaret L. Green, François-Xavier Lescure, Emanuele Nicastri, Rentaro Oda, Kikuo Yo, Eugenia Quiros-Roldan, Alex Studemeister,…
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2020-04-10
Descripción: Remdesivir, a nucleotide analogue prodrug that inhibits viral RNA polymerases, has shown in vitro activity against SARS-CoV-2. -
Autor: Dörnemann, Jenny, Chiara Burzio, Axelle Ronsse, Armand Sprecher, Hilde De Clerck, Michel Van Herp, Marie-Claire Kolié, Vesselina Yosifiva, Severine Caluwaerts, Anita K. McElroy, and Annick Antierens.
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2017-01-15
Descripción: A neonate born to an Ebola virus-positive woman was diagnosed with Ebola virus infection on her first day of life. -
Autor: WHO
Tema: Treatment & Care
Tipo de elemento: Publicación
Fecha de actualización: 2019-05
Descripción: Considerable variability exists in the level of supportive care offered to Ebola patients, and this guideline provides recommendations for the management of adults and children to provide the best possible chance for survival. -
Autor: U.S. Food and Drug Administration
Tema: Treatment & Care
Tipo de elemento: Guía
Fecha de actualización: 2017-01-01
Descripción: This guidance represents the current thinking of the Food and Drug Administration (FDA or Agency) on this topic. It does not establish any rights for any person and is not binding on FDA or the public. You can use an alternative approach if it…Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Autor: WHO
Tema: Treatment & Care
Tipo de elemento: Guía
Fecha de actualización: 2018-08-27
Descripción: A group of independent scientific experts were convened by the WHO for the purpose of updating the May 2018 statement on MEURI for Ebola virus disease (EVD) during the current outbreak, 27 August 2018. (1)